Clinical Relevance of Isoagglutinin Rebound in Adult ABO-Incompatible Living Donor Liver Transplantation

Clinical Relevance of Isoagglutinin Rebound in Adult ABO-Incompatible Living Donor Liver Transplantation

ABO-incompatible (ABO-I) living donor liver transplantation (LDLT) can be performed successfully. However, anti-ABO isoagglutinin rebound may cause antibody-mediated rejection (AMR) and graft loss. The risk threshold of isoagglutinin rebound is still not defined. 76 ABO-I LDLT recipients were divide...

Full description

Bibliographic Details
Main Authors: Wei-Chen Lee, Chen-Fang Lee, Tsung-Han Wu, Hao-Chien Hung, Jin-Chiao Lee, Yu-Chao Wang, Chih-Hsien Cheng, Ting-Jung Wu, Hong-Shiue Chou, Kun-Ming Chan
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Journal of Personalized Medicine
Subjects:
ABO-incompatibility
liver transplantation
rituximab
bortezomib
case series
Online Access:https://www.mdpi.com/2075-4426/11/12/1300

Internet

https://www.mdpi.com/2075-4426/11/12/1300

Similar Items